New York/London, 30 July 2020 – Tiziana Life Sciences plc (“Tiziana”, AIM: TILS, NASDAQ: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and
CE Marking of COVID-19 lateral flow antibody test for professional use
Expansion of Partnership with Daewoong Pharmaceutical to Include COVID-19 Neutrali s ing Affimer Therapy
KEFI Minerals (AIM: KEFI), the gold exploration and development company with projects in the Federal Democratic Republic of Ethiopia and the Kingdom of Saudi Arabia, is pleased to provide its
Paris, France and Camberley, UK – 27 July 2020 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces an R&D update.
Symphony Environmental Technologies Plc (AIM: SYM), is pleased to announce positive antiviral test results from Eurofins Laboratories for its d2p antimicrobial masterbatch technology.
Southampton, UK – 21 July 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company which originated from research at the University of Southampton, issues clarification with respect
New York/London, 20 July 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel molecules
Patients who received SNG001 had a 79% lower risk of developing severe disease compared to placebo Patients who received SNG001 were more than twice as likely to recover from COVID-19
Cathal Friel, Executive Chairman of Open Orphan, said:
Beowulf (AIM: BEM; Spotlight : BEO), the mineral exploration and development company, announces that drilling at Kallak, scheduled for Autumn 2020, has been postponed because of COVID-19 and until such
